Results
34
34 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
GALD | CHF 114.50 | -2.2% | n/a | CHF 27.2b | CHF 107.26 | PS7x | E36.6% | n/a | ||
ILMN | US$100.24 | -4.5% | -30.1% | US$15.9b | US$147.56 | PS3.6x | E56.7% | 3.1% | ||
UCB | €182.25 | -4.7% | 91.0% | €34.6b | €202.88 | PE144.1x | E28.4% | 0.7% | ||
ARGX | €614.60 | -3.0% | 66.6% | €37.3b | €632.14 | PS20.5x | E41.8% | n/a | ||
NTRA | US$173.39 | 0.7% | 147.7% | US$22.9b | US$179.67 | PS14.9x | E70.4% | n/a | ||
ALNY | US$256.45 | -6.4% | 74.5% | US$33.2b | US$300.27 | PS14.8x | E58.8% | n/a | ||
SRPT | US$107.95 | -4.2% | -19.8% | US$10.3b | US$181.78 | PE84.6x | E30.1% | n/a | ||
A196170 | ₩398,500.00 | 1.7% | 345.7% | ₩21.2t | ₩565,000.00 | PS285.6x | E140.6% | n/a | ||
ONC | US$230.86 | 5.1% | 55.7% | US$24.6b | US$284.05 | PS7.6x | E66.6% | n/a | ||
ITCI | US$127.82 | 0.6% | 69.0% | US$13.6b | US$132.73 | PS22.1x | E52.9% | n/a | ||
RVTY | US$112.26 | -2.2% | 9.6% | US$13.7b | US$141.19 | PE48.3x | E20.2% | 0.2% | ||
VRTX | US$459.00 | -2.3% | 8.7% | US$117.9b | US$497.87 | PS10.7x | E29.5% | n/a | ||
VTRS | US$10.80 | 1.7% | -17.3% | US$12.9b | US$13.20 | PS0.9x | E52.4% | 4.4% | ||
ABBV | US$192.87 | 1.3% | 8.7% | US$340.5b | US$204.90 | PE80.3x | E25.3% | 3.4% | ||
TECH | US$65.94 | -5.7% | -7.9% | US$10.4b | US$86.96 | PE65.9x | E21.9% | 0.5% | ||
2269 | HK$23.45 | 7.6% | 41.3% | HK$96.1b | HK$21.72 | PE34.1x | E16.5% | n/a | ||
A068270 | ₩181,500.00 | 1.4% | 4.5% | ₩38.5t | ₩235,952.38 | PE205.8x | E74.1% | 0.4% | ||
LLY | US$844.27 | -2.8% | 8.0% | US$760.2b | US$981.47 | PE71.8x | E21.7% | 0.7% | ||
SOBI | SEK 316.00 | -1.6% | 21.5% | SEK 108.5b | SEK 369.67 | PE27.9x | E16.8% | n/a | ||
BMRN | US$64.85 | 2.1% | -26.9% | US$12.4b | US$96.86 | PE38.3x | E24.1% | n/a | ||
GSK | UK£14.20 | -3.1% | -15.0% | UK£57.9b | UK£17.89 | PE22.5x | E18.3% | 4.3% | ||
4503 | JP¥1,477.00 | 1.7% | -12.2% | JP¥2.6t | JP¥1,930.63 | PS1.4x | E41.6% | 5.0% | ||
MEDP | US$340.18 | -4.0% | -13.1% | US$10.4b | US$342.93 | PE25.6x | E9.5% | n/a | ||
BMY | US$53.90 | -2.9% | 8.1% | US$109.4b | US$61.24 | PS2.3x | E34.4% | 4.6% |